Sorafenib Concomitantly Used With TACE (Transarterial Chemoembolization) in uHCC (Unresectable Hepatocellular Carcinoma) Patients in China

Clinical trial NCT01839630 · COMPLETED

Trial details

NCT number: NCT01839630
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Carcinoma, Hepatocellular

Start date: 2013-05-30
Primary completion: 2016-08-06
Enrollment: 302

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.